TipRanks on MSN

Bristol-Myers Squibb’s Luspatercept Study: A Potential Game-Changer for Alpha-Thalassemia

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...
The Clinton Herald

TO YOUR GOOD HEALTH: Surgery is prudent if conservative treatment of neuroma fails

I am a 68-year-old woman who is in relatively good health. My primary exercise is walking my dogs anywhere from 2-5 miles per ...